Exercise capacity, muscle strength and fatigue in sarcoidosis

European Respiratory Journal

Volumn 38, Issue 3, 2011, Pages 628-634

  Marcellis, R G J ^a   Lenssen, A F ^a   Elfferich, M D P ^a   De Vries, J ^a,b   Kassim, S ^a   Foerster, K ^a   Drent, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Exercise capacity; Fatigue; Inspiratory muscle strength; Peripheral muscle strength; Sarcoidosis

Indexed keywords

METHOTREXATE; PREDNISONE;

ADIPOSE TISSUE; ADULT; ARM MUSCLE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE MARKER; FATIGUE ASSESSMENT SCALE QUESTIONNAIRE; FEMALE; FLEXOR MUSCLE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HAMSTRING; HUMAN; HUMAN TISSUE; LEG MUSCLE; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAXIMAL INSPIRATORY PRESSURE; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NETHERLANDS; PHYSICAL CAPACITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT PARAMETERS; SARCOIDOSIS; THORAX RADIOGRAPHY; TORQUE; WALKING;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLES; PULMONARY MEDICINE; QUESTIONNAIRES; SARCOIDOSIS;

EID: 80053086459     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00117710     Document Type: Article

References (30)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. De Vries J, Rothkrantz-Kos S, Van Dieijen-Visser MP, et al. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 127-136. (Pubitemid 38954753)
3. De Vries J, Wirnsberger RM. Fatigue, quality of life and health status in sarcoidosis. Eur Respir Mon 2005; 32: 92-104.
4. Drent M, Wirnsberger RM, De Vries J, et al. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 1999; 13: 718-722. (Pubitemid 29234767)
5. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-38. (Pubitemid 40101015)
6. Bourbonnais JM, Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J 2008; 32: 296-302.
7. Alhamad EH. The six-minute walk test in patients with pulmonary sarcoidosis. Ann Thorac Med 2009; 4: 60-64.
8. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132: 207-213. (Pubitemid 47068223)
9. Kabitz HJ, Lang F, Walterspacher S, et al. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest 2006; 130: 1496-1502. (Pubitemid 44786745)
10. Miller A, Brown LK, Sloane MF, et al. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107: 323-329.
11. Wirnsberger RM, Drent M, Hekelaar N, et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997; 10: 1450-1455. (Pubitemid 27311054)
12. Quanjer Ph. H, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
14. Freedson PS, Gilliam TB, Mahoney T, et al. Industrial torque levels by age group and gender. Isokinet Exerc Sci 1993; 3: 34-42.
15. Drouin JM, Valovich-McLeod TC, Shultz SJ, et al. Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol 2004; 91: 22-29. (Pubitemid 38292346)
16. Werle S, Goldhahn J, Drerup S, et al. Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population. J Hand Surg Eur Vol 2009; 34: 76-84.
17. Bohannon RW. Make tests and break tests of elbow flexor muscle strength. Phys Ther 1988; 68: 193-194. (Pubitemid 18053556)
18. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
19. Harik-Khan RI, Wise RA, Fozard JL. Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998; 158: 1459-1464.
20. Michielsen HJ, De Vries J, Van Heck GL, et al. Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS). Eur J Psychol Assess 2004; 20: 39-48. (Pubitemid 38118545)
21. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28: 551-558.
22. Trompenaars FJ, Masthoff ED, Van Heck GL, et al. Content validity, construct validity, and reliability of the WHOQOL-BREF in a population of Dutch adult psychiatric outpatients. Qual Life Res 2005; 14: 151-160. (Pubitemid 40249089)
23. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, et al. Prevalence of physical activity and inactivity among Saudis aged 30-70 years. A population-based cross-sectional study. Saudi Med J 2007; 28: 559-568. (Pubitemid 47046036)
24. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010; 36: 81-88.
25. De Kleijn WP, De Vries J, Lower EE, et al. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 2009; 15: 499-506.
26. Wiroth JB, Filippi J, Schneider SM, et al. Muscle performance in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 2005; 11: 296-303. (Pubitemid 40439684)
27. Ho LY, Mok CC, To CH, et al. Rituximab for refractory rheumatoid arthritis: a 24-week open-label prospective study. Open Rheumatol J 2007; 1: 1-4.
28. Baughman RP, Lower EE. Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med 2007; 13: 439-444. (Pubitemid 47472308)
29. Gibbons WJ, Fruchter N, Sloan S, et al. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21: 87-93. (Pubitemid 32275133)
30. Bohannon RW. Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 1997; 78: 26-32. (Pubitemid 27034240)